WFRF:(Normark Johan)
Search: WFRF:(Normark Johan) > A 2-Pyridone-Amide ...
- 20 of 97
- Previous record
- Next record
- To hitlist
A 2-Pyridone-Amide Inhibitor Targets the Glucose Metabolism Pathway of Chlamydia trachomatis
-
- Engström, Patrik (author)
- Umeå universitet,Institutionen för molekylärbiologi (Medicinska fakulteten),Molekylär Infektionsmedicin, Sverige (MIMS),Umeå Centre for Microbial Research (UCMR)
-
- Krishnan, K. Syam (author)
- Umeå universitet,Umeå Centre for Microbial Research (UCMR),Kemiska institutionen
- Ngyuen, Bidong D. (author)
- show more...
- Bastidas, Robert J. (author)
- Welch, Matthew D. (author)
- Hultgren, Scott J. (author)
- Valdivia, Raphael H. (author)
- show less...
- (creator_code:org_t)
- 2015
- 2015
- English.
- In: mBio. - 2161-2129 .- 2150-7511. ; 6:1
- Journal article (peer-reviewed)
Abstract
Subject headings
Close
- In a screen for compounds that inhibit infectivity of the obligate intracellular pathogen Chlamydia trachomatis, we identified the 2-pyridone amide KSK120. A fluorescent KSK120 analogue was synthesized and observed to be associated with the C. trachomatis surface, suggesting that its target is bacterial. We isolated KSK120-resistant strains and determined that several resistance mutations are in genes that affect the uptake and use of glucose-6-phosphate (G-6P). Consistent with an effect on G-6P metabolism, treatment with KSK120 blocked glycogen accumulation. Interestingly, KSK120 did not affect Escherichia coli or the host cell. Thus, 2-pyridone amides may represent a class of drugs that can specifically inhibit C. trachomatis infection. IMPORTANCE Chlamydia trachomatis is a bacterial pathogen of humans that causes a common sexually transmitted disease as well as eye infections. It grows only inside cells of its host organism, within a parasitophorous vacuole termed the inclusion. Little is known, however, about what bacterial components and processes are important for C. trachomatis cellular infectivity. Here, by using a visual screen for compounds that affect bacterial distribution within the chlamydial inclusion, we identified the inhibitor KSK120. As hypothesized, the altered bacterial distribution induced by KSK120 correlated with a block in C. trachomatis infectivity. Our data suggest that the compound targets the glucose-6-phosphate (G-6P) metabolism pathway of C. trachomatis, supporting previous indications that G-6P metabolism is critical for C. trachomatis infectivity. Thus, KSK120 may be a useful tool to study chlamydial glucose metabolism and has the potential to be used in the treatment of C. trachomatis infections.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Mikrobiologi inom det medicinska området (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Microbiology in the medical area (hsv//eng)
Publication and Content Type
- ref (subject category)
- art (subject category)
- 20 of 97
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Engström, Patrik
- Krishnan, K. Sya ...
- Ngyuen, Bidong D ...
- Chorell, Erik
- Normark, Johan
- Silver, Jim
- show more...
- Bastidas, Robert ...
- Welch, Matthew D ...
- Hultgren, Scott ...
- Wolf-Watz, Hans
- Valdivia, Raphae ...
- Almqvist, Fredri ...
- Bergström, Sven
- show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
- MEDICAL AND HEAL ...
- and Basic Medicine
- and Microbiology in ...
- Articles in the publication
- mBio
- By the university
- Umeå University
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
